The NIH offers this grant to accelerate drug and device discovery for mental health and substance use disorders. It aims to support the development and validation of tools for therapeutic studies, as well as early-stage human studies for drug candidates and devices related to mental disorders, SUDs, or alcohol addiction. The grant encourages advancements in preclinical development and testing of new candidate agents and neurostimulation approaches. Collaboration between academia and industry is strongly promoted. Application deadline: Feb 24, 2020.
Opportunity ID: 298891
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-230 |
| Funding Opportunity Title: | National Cooperative Drug/Device Discovery/Development Groups (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 21, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Feb 24, 2020 |
| Current Closing Date for Applications: | Feb 24, 2020 |
| Archive Date: | Mar 31, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) State governments Public housing authorities/Indian housing authorities Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this initiative is to: accelerate innovative drug and device discovery; develop pharmacologic and neuromodulatory tools for basic and clinical research on mental health, substance use disorders (SUDs) or alcohol addiction; develop and validate tools (pharmacologic or neurostimulation) in support of experimental therapeutic studies of innovative new candidates for mental disorders; and support early stage human studies to rapidly assess the safety, tolerability, and pharmacodynamics of promising drug candidates/devices and new indications for novel Investigational New Drug (IND)-ready agents or Pre-Market Approval (PMA)-ready devices for the treatment of mental disorders, SUDs or alcohol addiction. This FOA encourages applications to advance the discovery, preclinical development, and proof of concept (PoC) testing of new, rationally based candidate agents and neurostimulation approaches to treat mental disorders or SUDs or alcohol addiction, and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets. Partnerships between academia and industry are strongly encouraged. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-230.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00236472 | Jan 24, 2018 | Feb 24, 2020 | View |
Package 1
Mandatory forms
298891 RR_SF424_2_0-2.0.pdf
298891 PHS398_CoverPageSupplement_4_0-4.0.pdf
298891 RR_OtherProjectInfo_1_4-1.4.pdf
298891 PerformanceSite_2_0-2.0.pdf
298891 RR_KeyPersonExpanded_2_0-2.0.pdf
298891 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
298891 RR_Budget_1_4-1.4.pdf
298891 RR_SubawardBudget30_1_4-1.4.pdf
298891 PHS398_ModularBudget_1_2-1.2.pdf
298891 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
